Keeps Pharma Participates in KB Securities 'SmallCap Corporate Day' for Institutional Investor IR, Limited Short-Term Impact

Keeps Pharma will participate in KB Securities' '2026 H1 KB SmallCap Corporate Day' via Zoom on June 8, 2026, to hold an IR meeting with major domestic institutional investors.
The IR aims to enhance investor understanding and improve corporate value, featuring company introduction, key development updates, and Q&A.
This disclosure pertains to routine IR activities without capital raising or equity changes, thus having no direct impact on shareholder value.
[AI Summary]This IR is a routine institutional investor briefing with no financial events or equity changes, rated as neutral. It is unlikely to significantly affect short-term stock price but serves as an opportunity to communicate the company's growth story.